Y10S 977/717
Lipid substrate
Y10S977/717 (Lipid substrate) appears on 7 US grants and 7 published applications in this corpus.
Search patents in Y10S- Granted patents
- 7
- Published applications
- 7
- Assignees
- 8
- Inventors
- 15
- Latest grant
- 18 Feb 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer18 Feb 2014US 8,652,464 B2Alkermes Pharma Ireland Limited
- Nanoparticulate compositions having lysozyme as a surface stabilizer4 Dec 2012US 8,323,641 B2Alkermes Pharma Ireland Limited
- Formation and encapsulation of molecular bilayer and monolayer membranes18 Oct 2011US 8,038,885 B2The Regents of the University of California
- Nanoparticle formulations of platinum compounds3 Nov 2009US 7,611,733 B2Cell Therapeutics Europe S.R.L.
- Nanoparticulate compositions having lysozyme as a surface stabilizer2 Dec 2008US 7,459,283 B2Elan Pharma International Limited
- Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer21 Aug 2014US 2014/0234225 A1Alkermes Pharma Ireland Limited
- Nanoparticulate compositions having lysozyme as a surface stabilizer29 Aug 2013US 2013/0224123 A1Alkermes Pharma Ireland Limited
- Formation and Encapsulation of Molecular Bilayer and Monolayer Membranes2 Jul 2009US 2009/0170118 A1The Regents of the University of California
- Nanoparticulate compositions having lysozyme as a surface stabilizer19 Mar 2009US 2009/0074875 A1Elan Pharma International Limited
- Nanoparticle Formulations Of Platinum Compounds14 Feb 2008US 2008/0038371 A1Cell Therapeutics Europe S.R.L.
Most cited
By later US patents
- Nanostructured separation and analysis devices for biological membranes169US 6,913,697 B2Science & Technology Corporation @ UNM · 2005
- Nanoparticulate compositions having lysozyme as a surface stabilizer25US 7,459,283 B2Elan Pharma International Limited · 2008
- Method to increase the stability of nanocapsules during storage thereof15US 5,885,491 ALaboratorios Cusi, S.A. · 1999
- Formation and encapsulation of molecular bilayer and monolayer membranes8US 8,038,885 B2The Regents of the University of California · 2011
- Nanoparticulate compositions having lysozyme as a surface stabilizer1US 8,323,641 B2Alkermes Pharma Ireland Limited · 2012